000903613 001__ 903613
000903613 005__ 20211221142255.0
000903613 0247_ $$2doi$$a10.1016/j.biopsych.2021.02.440
000903613 0247_ $$2ISSN$$a0006-3223
000903613 0247_ $$2ISSN$$a1873-2402
000903613 037__ $$aFZJ-2021-05267
000903613 1001_ $$0P:(DE-Juel1)184653$$aKasper, Jan$$b0$$eCorresponding author$$ufzj
000903613 1112_ $$aSociety of Biological Psychiatry$$cDigital$$d2021-04-29 - 2021-05-01$$gSOBP$$wUSA
000903613 245__ $$aFunctional MRI Derived Resting-State Alterations in Huntington’s Disease are Associated With the Distribution of Serotonergic and Dopaminergic Neurotransmitter Systems
000903613 260__ $$c2021
000903613 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1640078201_1957
000903613 3367_ $$033$$2EndNote$$aConference Paper
000903613 3367_ $$2BibTeX$$aINPROCEEDINGS
000903613 3367_ $$2DRIVER$$aconferenceObject
000903613 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000903613 3367_ $$2ORCID$$aOTHER
000903613 520__ $$aHuntington’s disease (HD) is characterized by progressive striatal atrophy and widespreaddegeneration during the course of disease. Functionally, altered resting-state activity andconnectivity in networks involving cortical, subcortical and cerebellar regions can beobserved. The relationship of brain alterations in HD with specific neurotransmitter systemsremains largely unknown. We evaluated whether resting-state alterations in HD are associated with the known in vivodistribution of various neurotransmitter systems including serotonin, GABA, dopamine andnorepinephrine. Maps of resting-state activity derived from functional magnetic resonanceimaging were computed for 32 HD patients and 30 healthy controls. We tested whetheralterations in HD were associated with the distribution of specific neurotransmitter systemsand their coding mRNA gene expressions. Finally, we examined the association of theserelationships with HD clinical phenotypes and if these associations can be replicated in anindependent cohort (HD: N=29; controls: N=39).HD functional alterations were significantly related to the distribution of dopamine andserotonin receptors (D1, D2, 5-HT1b) and transporters, as well as with mRNA expressions ofgenes encoding the corresponding dopamine proteins. The co-localization with D1 wascorrelated in HD with motor (r=-0.5,p=0.004) and functional (r=0.5,p=0.003) impairment.These findings were largely replicated in a second cohort.We show that resting-state functional alterations in HD follow the spatial distribution ofdopaminergic and serotonergic systems. The strength of these associations was linked to theobserved symptom severity. These findings provide novel insight intoneuropathophysiological mechanisms underlying functional alterations in HD and thisapproach may aid characterizing less researched neurodegenerative diseases.
000903613 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000903613 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000903613 7001_ $$0P:(DE-Juel1)131678$$aEickhoff, Simon B.$$b1$$ufzj
000903613 7001_ $$0P:(DE-HGF)0$$aPeter, Jessica$$b2
000903613 7001_ $$0P:(DE-HGF)0$$aDogan, Imis$$b3
000903613 7001_ $$0P:(DE-HGF)0$$aWolf, Robert Christian$$b4
000903613 7001_ $$0P:(DE-Juel1)177889$$aReetz, Kathrin$$b5$$ufzj
000903613 7001_ $$0P:(DE-Juel1)177772$$aDukart, Juergen$$b6$$eLast author
000903613 7001_ $$0P:(DE-HGF)0$$aOrth, Michael$$b7$$eLast author
000903613 773__ $$a10.1016/j.biopsych.2021.02.440$$gVol. 89, no. 9, p. S172 -$$y2021
000903613 909CO $$ooai:juser.fz-juelich.de:903613$$pVDB
000903613 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)184653$$aForschungszentrum Jülich$$b0$$kFZJ
000903613 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131678$$aForschungszentrum Jülich$$b1$$kFZJ
000903613 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177889$$aForschungszentrum Jülich$$b5$$kFZJ
000903613 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000903613 9141_ $$y2021
000903613 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-28$$wger
000903613 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBIOL PSYCHIAT : 2019$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-28
000903613 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bBIOL PSYCHIAT : 2019$$d2021-01-28
000903613 920__ $$lyes
000903613 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
000903613 980__ $$aabstract
000903613 980__ $$aVDB
000903613 980__ $$aI:(DE-Juel1)INM-7-20090406
000903613 980__ $$aUNRESTRICTED